Molecular Risk Stratification in Aggressive B-Cell Lymphomas

被引：3
|
作者：
Frosch, Zachary A. K. [1 ]
Landsburg, Daniel J. [2 ]
机构：
[1] Univ Penn, Perelman Sch Med, Div Hematol Oncol, Philadelphia, PA 19104 USA
[2] Univ Penn, Lymphoma Program, Abramson Canc Ctr, Philadelphia, PA 19104 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 18期
关键词：
MYC REARRANGEMENTS; SURVIVAL; CYCLOPHOSPHAMIDE; VINCRISTINE; DOXORUBICIN; RITUXIMAB;
D O I：
10.1200/JCO.19.03069
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：2014 / +
页数：5
相关论文
共 50 条
  • [31] Anatomical Pattern of CNS Relapse in Aggressive B-cell Lymphomas
    Okcu, Izel
    Abeykoon, Jithma P.
    Wang, Yucai
    Moustafa, Muhamad Alhaj
    Munoz, Javier L.
    Johnston, Patrick B.
    Witzig, Thomas E.
    Kabat, Brian F.
    Habermann, Thomas M.
    Nowakowski, Grzegorz S.
    Tun, Han W.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S472 - S473
  • [32] Genetic background and evolution of relapses in aggressive B-cell lymphomas
    Juskevicius, Darius
    Dirnhofer, Stephan
    Tzankov, Alexandar
    HAEMATOLOGICA, 2017, 102 (07) : 1139 - 1149
  • [33] Bptf determines oncogenic addiction in aggressive B-cell lymphomas
    Laia Richart
    Irene Felipe
    Pilar Delgado
    Mónica P. de Andrés
    Jaime Prieto
    Natalia del Pozo
    Juan F. García
    Miguel A. Piris
    Almudena Ramiro
    Francisco X. Real
    Oncogene, 2020, 39 : 4884 - 4895
  • [34] Small molecule phenotypic targeting of aggressive B-cell lymphomas
    Cardenas, Mariano G.
    Teater, Matt R.
    Calvo-Vidal, Nieves
    Yang, Shao Ning
    Glickman, J. F.
    Melnick, Ari
    Cerchietti, Leandro
    CANCER RESEARCH, 2014, 74 (19)
  • [35] Bptf determines oncogenic addiction in aggressive B-cell lymphomas
    Richart, Laia
    Felipe, Irene
    Delgado, Pilar
    de Andres, Monica P.
    Prieto, Jaime
    del Pozo, Natalia
    Garcia, Juan F.
    Piris, Miguel A.
    Ramiro, Almudena
    Real, Francisco X.
    ONCOGENE, 2020, 39 (25) : 4884 - 4895
  • [36] Approaches to aggressive B-cell lymphomas in less fit patients
    Bartlett, Nancy L.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2020, (01) : 140 - 147
  • [37] Fluorescence in situ hybridization in the diagnosis of aggressive B-cell lymphomas
    Gerhard-Hartmann, Elena
    Rosenwald, Andreas
    PATHOLOGE, 2020, 41 (06): : 574 - 581
  • [38] Morphological, immunophenotypic and molecular characterization of mature aggressive B-cell lymphomas in Chinese pediatric patients
    Lu, Beibei
    Zhou, Chunju
    Yang, Wenping
    Huang, Hui
    Gao, Zifen
    He, Yaoxin
    Liu, Hongxiang
    Zhou, Xiaoge
    Gong, Liping
    LEUKEMIA & LYMPHOMA, 2011, 52 (12) : 2356 - 2364
  • [39] HIGH RISK AGGRESSIVE B-CELL LYMPHOMAS IDENTIFIED BY FISH: A MULTICENTRIC ITALIAN RETROSPECTIVE STUDY
    Tisi, M. C.
    Ferrero, S.
    Carli, G.
    Dogliotti, I.
    Novo, M.
    Rattotti, S.
    Mosna, F.
    Loseto, G.
    Fama, A.
    Di Rocco, A.
    Pelosini, M.
    Marino, D.
    Tomei, G.
    Calimeri, T.
    Olivieri, J.
    Sgherza, N.
    Giannoccaro, M.
    Mazzone, A. M.
    Gherlinzoni, F.
    Visco, C.
    Zaja, F.
    HAEMATOLOGICA, 2017, 102 : 35 - 35
  • [40] Another disappointment in treating relapsed, refractory high-risk aggressive B-cell lymphomas
    Eyre, Toby A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (02) : 202 - 204
12345